Provider review
InstaRX review
Promises the same price at any dose on four pages, and publishes three different prices.
A quarter dose costs a full dose here — that part is stated repeatedly and clearly. What is not clear is which number you pay. Three are live for the same drug, and one of them needs a year up front.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
InstaRX
$179/mo semaglutide, same price any dose
- Vs median
- $10/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Take a quarter dose here and you pay for a full one; InstaRX says so on four separate pages, which is more honesty about the structure than most manage. It also does two things worth crediting: it admits its testimonials are paid and unverified, in its own words, and it publishes a potency-testing tolerance and cadence rather than a vague quality claim. Then the pages stop agreeing with each other. Three prices for the same compounded semaglutide are live at once — one on the weight-loss page, one in the home page title, and a third on the product page that turns out to need twelve months paid up front. No page reconciles them. The product page for semaglutide also describes a tirzepatide product, carries a title about a completely different supplement, and prints a testimonial thanking another company. Treat every figure here as unconfirmed until someone quotes you one in writing.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are starting low and expect to climb, and want the rate to hold while you do
- You want a stated potency-testing tolerance and cadence rather than a general quality claim
- You are willing to get a written quote before paying, and to hold the seller to it
Look elsewhere if
- You are taking less to spend less. The price does not move when the dose does
- You need to know what you will be billed. Three figures for the same drug are live across the site
- You are relying on the lowest monthly figure on a product page. That one needs twelve months paid up front
- You want the pharmacy named, or a list of the states served
What it actually costs
Price as published
$179/mo compounded semaglutide and $259/mo compounded tirzepatide on /weight-loss, printed next to "Same price any dose" · two other figures compete with those: the home page title markets "Get Started For Just $199", and both product pages headline "Starting at $265/Month *" where the asterisk resolves to "*For 12 month prepayment" · no page reconciles the three · no week count is published, and the only stated commitment is the twelve-month prepayment behind $265
- Vs median
- $10/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. Every page that names a price also promises the price does not move with the dose, so a quarter dose is billed as a full one. Which figure you are actually billed is a separate problem: three compete across the site, one of them conditional on twelve months paid up front, and none is reconciled.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- Says "Same price any dose" on the product cards and repeats "Same price at every dose" on the product pages — the flat-dose commitment is stated four times, not once
- Carries an unusually candid testimonial disclosure: "Paid endorsements. Reviewers may have received cash, credit, or free product. Photos are customer-submitted. We did not independently verify weights, dates, or outcomes."
- Publishes a quality-testing claim with a stated tolerance and cadence — potency "Confirmed every 3–6 months to stay within ± 10 % of the target strength"
- The twelve-month-prepayment condition behind the $265 figure is disclosed on the page rather than only in the terms
- Displays a LegitScript seal linked to the certification checker
Pharmacy, labs and oversight
InstaRX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What InstaRX publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
InstaRX sells compounded semaglutide and compounded tirzepatide as weekly injections on a monthly plan, with a twelve-month prepayment option quoted as a monthly rate on both product pages. It disclaims being the provider: "InstaRX is a technology platform that facilitates access to independent third-party healthcare providers and pharmacies. InstaRX itself does not provide medical care, make treatment decisions, or dispense medications." Three different prices for the same molecule are live across its own pages at once, and no page reconciles them. No compounding pharmacy is named.
The honest cons
SAME PRICE ANY DOSE. A quarter dose is billed at the full-dose rate, and the gap is medication you bought and never took
- THREE PRICES ARE LIVE AT ONCE FOR COMPOUNDED SEMAGLUTIDE — $179/mo on /weight-loss, $199 in the home page title, and $265/mo with twelve months prepaid on the product page — and no page reconciles them
- The semaglutide product page describes the wrong molecule: "Compounded Semaglutide Injections... A next-generation compounded GLP-1/GIP injection with tirzepatide". Semaglutide is not a GIP agonist, and the tirzepatide page carries the identical sentence
- The semaglutide product page's own title is "NAD+ for Cellular & Energy Support | Telehealth | InstaRx", and the testimonial on it thanks a different company entirely: "I'm so lucky to have found NueYue."
- Claims "Trusted by over 1M Customers" and "Join 1,000,000+ weight loss patients" on a page that also shows "Excellent 680+ reviews"
- No compounding pharmacy is named — only "a state-licensed pharmacy, independently verified in FDA and DEA-registered labs"
- No list of states served is published, and no week count sits behind "/mo"
- InstaRX says it "does not provide medical care, make treatment decisions, or dispense medications", so the clinical and dispensing relationships are with parties it does not name
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
InstaRX is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#122 of 373
Ordered with the companies that pay us first, and InstaRX is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.